Pure Global AI
NCT06332794Not yet recruiting

Keep On Keep Up for Parkinson's

Keep On Keep Up (KOKU4PD) - Developing an App for People With Parkinson's Disease
Northumbria UniversityClinicalTrials.govdeviceDevice trial
Study focus
Disease/Condition
Parkinson's Disease
Drug/Device/Intervention
KOKU4PD
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Northumbria University
Location
Newcastle upon Tyne, United Kingdom
Timeline & enrollment
Phase
N/A
Start date
Jun 03, 2024
End date
Jun 30, 2025
Enrollment
20 participants
Primary outcome

Usability of the KOKU app

Summary

The goal of this mixed methods, user research study is to evaluate the Keep On Keep Up
 programme for people with Parkinson's (KOKU4PD).
 
 The main aims of the study are to:
 
 1. To explore the usability and acceptability of the PD specific KOKU programme from a user
 and health care professional perspective.
 
 2. To produce a KOKU4PD digital program that is ready for National Health Service (NHS)
 approval and a future effectiveness evaluation.
 
 Participants will use the KOKU4PD app at home for 4 weeks. They will be assessed at baseline
 and after the 4 weeks to measure aspects of their disease status, mobility, thinking, mood
 and quality of life. They will also be asked to complete some questionnaires about the
 usability of the app.

ICD-10 classifications
Parkinson diseaseParkinsonism in diseases classified elsewhereDementia in Parkinson diseaseSecondary parkinsonismPostencephalitic parkinsonism
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06332794
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06332794 through Pure Global AI's free database. This phase not specified trial is sponsored by Northumbria University and is currently Not yet recruiting. The study focuses on Parkinson's Disease. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.